Rise Advisors, LLC Sutro Biopharma, Inc. Transaction History
Rise Advisors, LLC
- $242 Million
- Q2 2025
A detailed history of Rise Advisors, LLC transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Rise Advisors, LLC holds 769 shares of STRO stock, worth $615. This represents 0.0% of its overall portfolio holdings.
Number of Shares
769Holding current value
$615% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding STRO
# of Institutions
118Shares Held
60.5MCall Options Held
95.8KPut Options Held
38.5K-
Suvretta Capital Management, LLC New York, NY7.46MShares$5.97 Million0.21% of portfolio
-
Black Rock Inc. New York, NY6.91MShares$5.53 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.44MShares$4.35 Million0.3% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.43MShares$3.55 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.4MShares$3.52 Million0.0% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $41.7M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...